Tag: WHO

  • COVID-19: Omicron spreading faster than Delta variant- WHO

    COVID-19: Omicron spreading faster than Delta variant- WHO

    The World Health Organisation (WHO) says there is now “consistent evidence” that the Omicron variant was outpacing Delta, as COVID-19 continues to account for around 50,000 deaths worldwide every week.

    WHO Director General, Tedros Ghebreyesus told journalists at the agency’s Headquarters in Geneva that it was also more likely that people who had been vaccinated, or recovered from the virus, could be infected, or re-infected.

    “There can be no doubt that increased social mixing over the holiday period in many countries will lead to increased cases, overwhelm health systems and more deaths.

    “All of us are sick of this pandemic. All of us want to spend time with friends and family. All of us want to get back to normal.

    “The fastest way to do that is for all of us – leaders and individuals – to make the difficult decisions that must be made to protect ourselves and others,” he said.

    He said delaying or cancelling events, was the responsible thing to do: “An event cancelled is better than a life cancelled. It’s better to cancel now and celebrate later, than to celebrate now and grieve later.”

    More than 3.3 million people have lost their lives to COVID-19 this year – more deaths than from HIV, malaria and tuberculosis combined in 2020, and Africa was now facing a steep wave of infections, driven largely by the Omicron variant.

    Just a month ago, Africa was reporting its lowest number of cases in 18 months, Ghebreyesus reminded reporters on Monday, whereas last week, it reported the fourth-highest number of cases in a single week so far.

    “None of us want to be here again in 12 months’ time, talking about missed opportunities, continued inequity, or new variants,” he said.

    The director general emphasised that for the pandemic to end in 2022, “we must end inequity, by ensuring 70 per cent of the population of every country is vaccinated by the middle of next year.”

    Around the world, the WHO was working with countries to restore and sustain essential health services disrupted by the pandemic.

    According to new data released this year, 23 million children missed out on routine vaccines in 2020, the largest number in over a decade, increasing risks from preventable diseases like measles and polio, the UN correspondent of the News Agency of Nigeria (NAN) reported.

    Progress is, however, still being made in many other areas of healthcare and medicine.

    Five countries were able to introduce the human papillomavirus vaccine (HPV) to prevent cervical cancer, and a further nine are planning to introduce it over the next six months, and in September, WHO launched a global road map to defeat meningitis by 2030.

    The pandemic has also caused setbacks in the agency’s efforts to defeat the world’s leading infectious diseases, with an estimated 14 million more malaria cases and 47 thousand more malaria deaths in 2020, compared to 2019.

    “However, WHO certified two countries – China and El Salvador – as malaria-free this year, and a further 25 are on track to end malaria transmission by 2025,” Ghebreyesus said.

    He said the WHO also made an historic recommendation for broad use of the world’s first malaria vaccine.

    Services for non-communicable diseases have also been hit, with more than half of countries surveyed between June and October, reporting disruptions to services for diabetes, cancer screening and treatment, and management of hypertension.

    Summing up a tumultuous year, he also noted that several important steps had been taken to strengthen the global health architecture, and WHO itself.

    “We launched the WHO Hub for Pandemic and Epidemic Intelligence in Berlin; We broke ground on the WHO Academy in Lyon; We established the WHO BioHub System,” he said.

    In early December, Member States agreed to negotiate the world’s first new agreement on pandemic preparedness and response.

    “We have also taken decisive steps to address instances of sexual exploitation and abuse and to make sure that our people meet the high standards that we, and our Member States, expect of them.

    “We took decisive steps to address sexual exploitation, following shocking revelations of alleged abuse committed by some WHO staff during the deadly tenth Ebola outbreak in the Democratic Republic of the Congo,’’ he said.

    “2022 must be the year we end the pandemic,” said the director general, but to prevent a future disaster on the same scale, all countries must invest in resilient health systems, build on primary care, with universal health coverage as the goal.

    “When people can’t access the services they need, or can’t afford them, individuals, families, communities and entire societies are put at risk.

    “In the year ahead, WHO is committed to doing everything in our power to end the pandemic, and to beginning a new era in global health – an era in which health is at the centre of every country’s development plans,” he said.

  • Nigeria accounts for 27% of global malaria deaths – WHO

    Nigeria accounts for 27% of global malaria deaths – WHO

    The World Health Organisation (WHO) says 29 of the 85 countries that were malaria-endemic accounted for about 96% of malaria cases and deaths globally while Nigeria accounted for 27% of deaths.

    The organisation disclosed this in its 2020 World Malaria report released on Monday.

    “About 96% of malaria deaths globally were in 29 countries. Six countries – Nigeria (27%), the Democratic Republic of the Congo (12%), Uganda (5%), Mozambique (4%), Angola (3%), and Burkina Faso (3%) – accounted for just over half of all malaria deaths globally in 2020.

    “Twenty-nine countries accounted for 96% of malaria cases globally, and six countries – Nigeria (27%), the Democratic Republic of the Congo (12%), Uganda (5%), Mozambique (4%), Angola (3.4%) and Burkina Faso (3.4%) – accounted for about 55% of all cases globally,” the report read in part.

    In the data provided, the WHO noted that while Africa had a total of 602,000 deaths out of the estimated 627,000, Nigeria accounted for 31.9 per cent of the malaria deaths on the planet, which was followed closely by the Democratic Republic of Congo with 13.2 percent.

    It also added that Sub-Saharan Africa had the heaviest malaria burden, accounting for about 95% of all malaria cases and 96% of all deaths in 2020. About 80% of deaths in the region are among children under 5 years of age.

    Commenting on the report, the Head, Global Malaria Programme, WHO, Dr Pedro Alonso, said there was a potential malaria crisis.

  • Governors beg WHO for intervention over UK, Canada’s travel ban on Nigerians

    Governors beg WHO for intervention over UK, Canada’s travel ban on Nigerians

    Members of the Nigeria Governors’ Forum (NGF) have condemned the travel ban imposed on the country by authorities in Canada and the United Kingdom over the report of confirmed cases of omicron COVID-19 variant.

    In a statement on Tuesday by NGF Chairman and Ekiti State Governor, Kayode Fayemi, they described the action of both countries, as discriminatory and called for the intervention of the World Health Organisation (WHO).

    “The Nigeria Governors’ Forum (NGF) wishes to draw the attention of the World Health Organisation (WHO) to the arbitrary stigmatisation that is caused by the recent banning of countries from visitation based on omicron spread,” said Governor Fayemi. “Only three cases of the Omicron variant of the coronavirus were detected in Nigeria less than a week ago, precisely on December 1st, 2021.

    “Canada and the United Kingdom have hastily included Nigeria among the Omicron present countries which must stay away from their shores, an action viewed by the NGF as precipitate, unfair and discriminatory.”

    According to the governors, omicron remains relatively unknown globally as it is not yet clear whether it is more transmissible from person to person, compared to other variants, including Delta.

    They stressed that it was very discouraging to note that several countries have reported cases of omicron with tallies similar to or higher than Nigeria’s, yet travellers there have not been banned from entering the UK and Canada.

    Confirmed omicron cases across some countries as of December 3, the NGF stated, included Nigeria (three), Australia (seven), Brazil (three), Germany (nine), Israel (four), Italy (nine), and Netherlands (16).

    “There is also no evidence that harsh, blanket travel bans will protect the countries that impose them,” said the governors. “It is ironical that this ban comes at a time when the DG of the WHO, Tedros Ghebreyesus, has advised that ‘rational proportional risk reduction measures’ be taken by countries such as screening passengers prior to departure and/or upon arrival in a country or enforcing a quarantine period.”

    “The NGF, therefore, urges the WHO to intervene in this matter by setting uniform standards that are acceptable to all for banning countries across the globe. As we know, vaccine hesitancy is quite high and for many reasons, including disruptive announcements like this which could exacerbate distrust of the vaccine and heighten hesitancy.

    “World leaders and stakeholders in the West need to remember that with the COVID-19 pandemic until everyone is free, no one is free. Variants will continue to appear and spread across the globe as long as global herd immunity has not been achieved.

    “We call on countries to be guided by science and fairness in setting the criteria for updating their red list. We encourage both public and private stakeholders to continue to support vaccination efforts and address hesitancy. We encourage Nigerians not to be discouraged and to get vaccinated as soon as possible.

    “As a platform for the 36 democratically elected governors of the country, the NGF believes it reserves the right to speak for its people. Besides, the NGF was proactive and ahead in the Polio eradication program in Nigeria, in the country’s response to the Ebola virus, and lately in the response against the coronavirus pandemic. Finally, health is one of the core mandate areas of the NGF and has remained an item on its meeting agenda in the past several months,” the NGF added.

  • No reported case of deaths arising from Omicron variant yet – WHO

    No reported case of deaths arising from Omicron variant yet – WHO

    The World Health Organization (WHO) on Friday said it had not seen any reports of deaths relating to the new Omicron variant of Covid-19.

    The WHO said it was collecting evidence about the variant of concern (VOC), as countries around the world scramble to stop it from spreading.

    But despite a growing number of countries registering infections with the new variant, no deaths have yet been reported to the UN health agency.

    “I have not seen reports of Omicron-related deaths yet,” WHO spokesman Christian Lindmeier told reporters in Geneva.

    “We’re collecting all the evidence and we will find much more evidence as we go along.

    “The more countries… keep testing people, and looking specifically into the Omicron variant, we will also find more cases, more information, and, hopefully not, but also possibly deaths.”

    While Omicron has rattled the world, Lindmeier also urged people to be mindful of the Delta variant, which accounts for 99.8 percent of sequences uploaded to the GISAID global science initiative with specimens collected in the last 60 days.

    “Omicron may be on the rise, and we may come to a point where it takes over to be the dominant variant, but at this point, the very dominant variant remains Delta,” he stressed.

    Lindmeier added: “The restrictions that were put into place in many countries just two weeks ago — economical closures again, lockdowns in some areas, closures of Christmas markets in parts of Europe — this was done before Omicron because of a rise of Delta cases. Let’s not lose sight of this.”

    The spokesman urged people to use proven measures to protect themselves against Delta — and thereby against Omicron.

    The WHO has said it will take several weeks to get a full picture of the transmissibility and disease severity of Omicron and to assess how vaccines, tests, and treatments hold up against the new variant.

    As Omicron spreads, pieces of information are emerging from various countries.

    “What we need to do is we need to take all these observations, assessments and tests and get this information together and then have the experts look at it, carefully weigh it and come up with the assessment. That will still take some time,” said Lindmeier.

    “Preliminary data show that there is higher transmissibility. But that’s basically all we have so far.”

  • COVID-19: Omicron variant now in 23 countries

    COVID-19: Omicron variant now in 23 countries

    The World Health Organisation (WHO) says cases of the new Omicron variant have been reported in at least 23 countries in five of the six WHO regions.

    WHO Director-General, Dr Tedros Ghebreyesus, disclosed on Wednesday in Geneva and said that the number of cases was expected to grow.

    “WHO takes this development extremely seriously, and so should every country,” he told journalists listening in to the agency’s regular virtual briefing on COVID-19.

    “But it should not surprise us. This is what viruses do. And it’s what this virus will continue to do, as long as we allow it to continue spreading,” he said.

    Preliminary evidence suggests Omicron may have “potential immune escape” and or possibly higher transmissibility, when compared to previous variants of concern, according to WHO’s latest weekly epidemiological update on COVID-19, also released on Wednesday.

    He said experts were learning more about the variant, “but there’s still more to learn about its effect on transmission, severity of disease, and the effectiveness of tests, therapeutics and vaccines.”

    The WHO chief urged countries to take “rational, proportional risk-reduction measures”, including those aimed at delaying or reducing spread, such as screening passengers or implementing quarantines for international travellers.

    However, he stressed that “blanket travel bans would not prevent international spread of Omicron and they place a heavy burden on lives and livelihoods.”

    Ghebreyesus emphasised the need to continue public health measures against coronavirus spread and ensure high-risk and vulnerable people are fully vaccinated.

    He warned that the current “toxic mix” of low vaccine coverage, and very low testing are a recipe for breeding and amplifying variants.

    “We need to use the tools we already have to prevent transmission and save lives from Delta.

    “And if we do that, we will also prevent transmission and save lives from Omicron. But if countries and individuals don’t do what they need to do to stop transmission of Delta, they won’t stop Omicron either,” he said.

    As of Tuesday, there were more than 261 million confirmed cases of the COVID-19 globally, and 5.2 million deaths, with the Delta variant continuing to dominate

    Meanwhile, the director-general said agreement by countries to launch a process to develop a new global accord on pandemic prevention and response was cause for hope.

    Ghebreyesus welcomed the consensus decision reached during a special session of the World Health Assembly (WHA), the UN agency’s top decision-making body, attended by representatives from its 194 member-states.

    The three-day meeting began on Monday with the sole goal of considering the benefits of creating a new international agreement on pandemic prevention preparedness and how best to avoid the pitfalls that have marred an effective response to COVID-19.

    This marked only the second time the assembly has met in a special session since WHO was founded in 1948.

    “The adoption of this decision is cause for celebration, and cause for hope, which we will need,” he said in his closing remarks, though noting the road ahead was long.

    “There are still differences of opinion about what a new accord could or should contain. But you have proven to each other and the world that differences can be overcome, and common ground can be found.”

    The decision will establish an Intergovernmental Negotiating Body (INB) that will negotiate and draft any convention, agreement or other international instrument.

    A first meeting will take place no later than March 1, 2022 and public hearings will also be held to inform deliberations.

    The INB will deliver a progress report to the World Health Assembly in 2023 and submit its outcome for consideration the following year.

  • WHO renames new COVID-19 variant

    WHO renames new COVID-19 variant

    The World Health Organization on Friday declared the recently-discovered B.1.1.529 strain of Covid-19 to be a variant of concern, renaming it Omicron.

    “Based on the evidence presented indicative of a detrimental change in Covid-19 epidemiology… the WHO has designated B.1.1.529 as a variant of concern, named Omicron,” the UN health agency said in a statement.

    Meanwhile, EU officials holding an emergency meeting over the variant agreed on Friday to urge all 27 nations in the bloc to restrict travel from that region.

    “Member States agreed to introduce rapidly restrictions on all travel into the EU from seven countries in the Southern Africa region: Botswana, eSwatini, Lesotho, Mozambique, Namibia, South Africa, Zimbabwe,” European Commission spokesman Eric Mamer tweeted.

    The measure was only a recommendation to suspend flights from those African nations.

    “This is not a formal decision but a recommendation. It is up to each member state to take its own decisions,” an EU official said.

    Many EU member states had already gone ahead with flight suspensions from some or all of the seven African countries. Others were expected to follow suit over coming days.

    An EU official said the diplomats and officials meeting in Brussels under the EU’s Integrated Political Crisis Response (IPCR) mechanism opted to emphasise “restrictions” over travel suspensions.

    That is because EU citizens and residents were allowed to return to their home countries — though will likely face PCR tests and quarantine on arrival.

    Non-EU citizens and residents would be barred from travelling into the EU under the agreed recommendation.

    The current Slovenian presidency of the European Union tweeted that the IPCR meeting agreed to activate an “emergency brake” allowing member states to rapidly change travel criteria to keep pace with changes brought on by Covid.

    The presidency “called upon members to test and quarantine all incoming passengers” in its tweet.

    There was no immediate fuller statement giving details, so it was not clear whether that meant passengers from the seven African countries, or all passengers arriving in the EU regardless of point of origin.

  • Europe hits highest weekly COVID-19 cases since pandemic began -WHO

    Europe hits highest weekly COVID-19 cases since pandemic began -WHO

    Almost two million cases of COVID-19 were reported in Europe last week, the most in a single week in that region since the pandemic started, according to the World Health Organisation (WHO).

    Almost 27,000 deaths were reported in the continent last week, more than half of all COVID-19 deaths globally.

    Speaking to journalists in Geneva, WHO Director-General, Dr Tedros Ghebreyesus, explained that the virus was not only surging in countries with lower vaccination rates in Eastern Europe, but also in nations with some of the world’s highest vaccination rates in Western Europe.

    “It’s another reminder, as we have said again and again, that vaccines do not replace the need for other precautions.

    “Vaccines reduce the risk of hospitalisation, severe disease and death, but they do not fully prevent transmission,” he said.

    WHO continues to recommend the proportionate use of testing, masks, physical distancing, improved ventilation, and other measures.

    “With the right mix of measures, it’s possible for countries to find the balance between keeping transmission down and keeping their societies and economies open.

    “No country can simply vaccinate its way out of the pandemic,” Ghebreyesus said.

    According to the WHO chief, “it makes no sense” to give boosters to healthy adults, or to vaccinate children, when health workers, older people and other high-risk groups around the world are still waiting for their first dose.

    Every day, there are six times more boosters administered globally than primary doses in low-income countries, which he described as “a scandal that must stop now”.

    The WHO chief also provided an update on COVAX, the UN-led worldwide initiative aimed at equitable access to vaccines.

    The tool has now shipped almost 500 million vaccines to 144 countries and territories. And with exception of Eritrea and the Democratic People’s Republic of Korea, all States have begun vaccinating.

    “The vast majority of countries are ready to get doses into arms, but they need the doses,” he said.

    To reach the target of vaccinating 40 per cent of every country’s population by the end of this year, 550 million doses more are needed – about 10 days’ worth of production.

    The pandemic has had effects on other vaccination campaigns, Ghebreyesus explained.

    A report by WHO and the U.S. Centers for Disease Control and Prevention, released this week, shows that more than 22 million infants missed their first dose of measles vaccine last year – three million more than in 2019 – marking the largest increase in two decades.

    A total of 24 measles vaccination campaigns in 23 countries were postponed because of the pandemic, leaving more than 93 million people at risk.

    Compared with 2019, however, reported cases decreased by more than 80 per cent.

    “But this decrease is cause for concern, not celebration,’’ he said, explaining that measures to prevent the spread of COVID-19 may have contributed, noting that lab specimens sent for testing were the lowest in a decade.

    “The drop in vaccination, combined with weak monitoring, testing and reporting, create the ideal conditions for explosive outbreaks of measles,” he said. (NAN)

  • BREAKING: Didier Drogba bags WHO appointment

    BREAKING: Didier Drogba bags WHO appointment

    Ivorian retired professional footballer, Mr Didier Drogba has been appointed World Health Organization (WHO) Ambassador for Sports and Health.

    TheNewsGuru.com (TNG) reports Mr Drogba was appointed ambassador by the WHO to help promote the benefits of physical activity, healthy lifestyles and the value of sports, particularly for youth.

    Drogba, well known for his football career at Chelsea and as a two-time African Footballer of the Year (2006 and 2009), has a long track record of participating in various health campaigns such as healthy lifestyles, anti-malaria and HIV prevention and control.

    “I am honoured to team up with the World Health Organization and support its work to help people reach the highest level of health possible, especially young people in all countries,” said Mr Drogba during his ambassadorship announcement event at WHO’s Geneva headquarters.

    He added: “I have benefited first hand from the power of sports to lead a healthy life and I am committed to working with WHO to share such gains worldwide.”

    Dr Tedros Adhanom Ghebreyesus, WHO Director-General, hailed Mr Drogba as not only a football legend but a dedicated advocate for the health and sustainable development of communities, and added that his support for WHO can help curb the growing burden of noncommunicable diseases (NCDs) through the promotion of healthy lifestyles, including the benefits of physical activity and sports for all people.

    “Didier is a proven champion and game changer both on and off the pitch,” said Dr Tedros. “We are pleased to have him playing on our team, and helping communities worldwide reach and score goals through sports for their physical and mental health and well-being. He will also support the mobilization of the international community to promote sports as an essential means for improving the physical, mental health and social well-being of all people, including in helping COVID-19 recovery efforts.”

    TNG reports current global estimates show four in five adolescents, and one in four adults, do not do enough physical activity. Increased physical inactivity also negatively impacts health systems, the environment, economic development, community well-being, and quality of life.

    Regular physical activity, including through sports, helps lower blood pressure and reduce the risk of hypertension, coronary heart disease, stroke, diabetes, and various types of cancer (including breast cancer and colon cancer).

    Mr Drogba’s announcement as a WHO Goodwill Ambassador was made during a ceremony to launch the “Healthy 2022 World Cup – Creating Legacy for Sport and Health” partnership between Qatar’s Ministry of Public Health and its Supreme Committee for Delivery and Legacy, WHO and world football’s governing body, FIFA.

    Mr Drogba joins other WHO ambassadors including champion Brazilian footballer Alisson Becker; Michael Bloomberg, founder of Bloomberg Philanthropies and three-term Mayor of the City of New York; Cynthia Germanotta, President of the Born This Way Foundation; and former UK Prime Minister Gordon Brown.

  • Mosquirix: WHO approves World’s first vaccine for prevention of Malaria

    Mosquirix: WHO approves World’s first vaccine for prevention of Malaria

    The World Health Organisation (WHO) yesterday endorsed the first ever vaccine to prevent malaria, debuting a tool that could save the lives of tens of thousands of children in Africa each year.

    Called Mosquirix, the new vaccine is given in three doses to children between ages five and 17 months, and a fourth dose roughly 18 months later. Following the clinical trials, the vaccine was tried out in three countries

    Malaria is among the oldest known and deadliest of infectious diseases, killing about half a million people each year, nearly all of them in sub-Saharan Africa and among them 260,000 children under age five.

    The new vaccine, made by GlaxoSmithKline, rouses a child’s immune system to thwart Plasmodium falciparum, the deadliest of five malaria pathogens and the most prevalent in Africa.

    The New York Times reported that the vaccine was not just a first for malaria, but the first developed for any parasitic disease.

    However, the report stated that in clinical trials, the vaccine had an efficacy of about 50 per cent against severe malaria in the first year, but dropped close to zero by the fourth year.

    In addition, it stressed that the trials did not measure the vaccine’s impact on preventing deaths, which has led some experts to question whether it is a worthwhile investment in countries with countless other intractable problems.

    But severe malaria accounts for up to half of malaria deaths and is considered “a reliable proximal indicator of mortality. I do expect we will see that impact,” Dr. Mary Hamel, who leads the WHO’s malaria vaccine implementation programme, said.

    A modelling study last year had estimated that if the vaccine were rolled out to countries with the highest incidence of malaria, it could prevent 5.4 million cases and 23,000 deaths in children younger than age five each year.

    A recent trial of the vaccine in combination with preventive drugs given to children during high-transmission seasons found that the dual approach was much more effective at preventing severe disease, hospitalisation and death than either method alone.

    To have a malaria vaccine that is safe, moderately effective and ready for distribution is “a historical event,” Director of WHO’s Global Malaria Programme, Dr. Pedro Alonso said.

    Parasites are much more complex than viruses or bacteria, and the quest for a malaria vaccine has been underway for a hundred years, he added, stressing, “It’s a huge jump from the science perspective to have a first-generation vaccine against a human parasite.”

    The malaria parasite is a particularly insidious enemy, because it can strike the same person over and over.

    In many parts of sub-Saharan Africa, even those where most people sleep under insecticide-treated bed nets, children have on average six malaria episodes a year.

    Even when the disease is not fatal, the repeated assault on their bodies can leave them weak and vulnerable to other pathogens, permanently altering the immune system.

    Malaria research is littered with vaccine candidates that never made it past clinical trials. Bed nets, the most widespread preventive measure, cut malaria deaths in children under age five by only about 20 per cent.

    Against that backdrop, the new vaccine, even with modest efficacy, is the best new development in the fight against the disease in decades, some experts said.

    “Progress against malaria has really stalled over the last five or six years, particularly in some of the hardest hit countries in the world,” said Ashley Birkett, who heads malaria programmes at PATH, a non-profit organisation focused on global health.

    With the new vaccine, “there’s potential for very, very significant impact there,” Birkett added.

    Following the clinical trials, the vaccine was tried out in three countries — Kenya, Malawi and Ghana — where it was incorporated into routine immunisation programmes.

    More than 2.3 million doses have been administered in those countries, reaching more than 800,000 children. That bumped up the percentage of children protected against malaria in some way to more than 90 per cent from less than 70 per cent, Hamel said.

    “The ability to reduce inequities in access to malaria prevention — that’s important. It was impressive to see that this could reach children who are currently not being protected,” Hamel added.

    It took years to create an efficient system to distribute insecticide-treated bed nets to families. By contrast, making Mosquirix a part of routine immunisation made it surprisingly easy to distribute, he Hamel added — even in the midst of the coronavirus pandemic, which prompted lockdowns and disrupted supply chains.

    “We aren’t going to have to spend a decade trying to figure out how to get this to children,” he said.

    This week, a working group of independent experts in malaria, child health epidemiology and statistics, as well as the WHO’s vaccine advisory group, met to review data from the pilot programmes and make their formal recommendation to Director-General of the WHO, Dr. Tedros Ghebreyesus.

    According to the NYT, the next step is for Gavi, the global vaccine alliance, to determine that the vaccine is a worthwhile investment.

    If the organisation’s board approves the vaccine — not guaranteed, given the vaccine’s moderate efficacy and the many competing priorities — Gavi will purchase the vaccine for countries that request it, a process that is expected to take at least a year.

    But as with COVID-19, problems with vaccine production and supply could considerably delay progress and the pandemic has also diverted resources and attention from other diseases, said Deepali Patel, who leads malaria vaccine programmes at Gavi.

    “COVID-19 is a big unknown in the room in terms of where capacity is currently in countries, and rolling out COVID-19 vaccines is a huge effort. We’re really going to have to see how the pandemic unfolds next year in terms of when countries will be ready to pick up all of these other priorities,” Patel said.

  • WHO appoints another Nigerian into COVID-19 Technical Advisory Group

    WHO appoints another Nigerian into COVID-19 Technical Advisory Group

    The World Health Organisation (WHO) has appointed a professor of virology, Oyewale Tomori, to serve as a member of its Technical Advisory Group on COVID-19 vaccine composition.

    The WHO announced the appointment of Tomori, a former vice-chancellor of the Redeemer’s University, Ede, in a statement on Wednesday.

    The UN body said that Technical Advisory Group on COVID-19 vaccine composition was an independent group of experts that would periodically review the evidence and analyse the implications of emerging variants of concerns on the performance of COVID-19 vaccines.

    “During those global consultations, the WHO and partners have noted the urgent needs for shared access to information, coordination and prioritisation, as well as joint action and supported the call for the development of a global risk monitoring and assessment framework.

    ”The group will elaborate o decision-making processes, trigger for such decision making, and stakeholder roles and responsibilities.

    “Following discussions, the Executive Director of WHO, recognises the need to establish Technical Advisory Group on COVID-19 Vaccine Composition to make recommendations to WHO on the methods to assess the impact of the variants of concerns on vaccines,

    ”The director also recognises the need to provide interpretation of available evidence on the effect of variants of concerns on vaccines, including but not limited to vaccine effectiveness and recommend to WHO, for each COVID-19 vaccine platform, adaptations (if any) needed so that vaccines continue to safely provide WHO-recommended levels of protection against variants of concerns,” the statement partly reads.

    Some members of the group, are Dr Supamit Chunsuttiwat, who is an advisor, Department of Disease Control, Ministry of Public Health Thailand; Cheryl Cohen a professor in epidemiology at the University of the Witwatersrand, South Africa.

    Others are a Professor Thomas Fleming, a member of the Scientific Steering Committee for the WHO Solidarity COVID-19 Vaccines Trial; David Goldblatt, a Professor of Vaccinology and Immunology as well as Dr Ziad Memish, a Senior Infectious Disease Consultant.